Key Insights

Highlights

Treatment Research

1 treatments under study, led by Milatuzumab

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT01663766Phase 1Terminated

Phase I Study of Milatuzumab for Graft Versus Host Disease

Showing all 1 trials

Research Network

Common Treatments

  • Milatuzumab1

Active Sponsors

  • Gilead Sciences1
  • Ohio State University1

Top Investigators

Related Conditions

  • Myelodysplastic Syndrome1
  • Nonhodgekin Lymphoma Nhlboth Follicular Diffuse Large Cell1
  • Multiple Myeloma Mm1
  • Gvhd Acute Or Chronic1
  • Chronic Myelogenous Leukemia Cml1

Activity Timeline